Skip to main content
[Preprint]. 2023 Feb 14:rs.3.rs-2388864. [Version 1] doi: 10.21203/rs.3.rs-2388864/v1

Figure 7. Upregulation of CXCR4 in residual disease of breast cancer.

Figure 7

A CXCR4 protein in 72 residual tumor tissues and 112 primary tumor samples from breast cancer patients was analyzed using RPPA. B CXCR4 protein in residual HER2+ breast cancer after treatment with trastuzumab and chemotherapy compared with primary HER2+ breast cancer. C Serum samples from breast cancer patients or healthy women was measured for SDF-1α with ELISA. Data were analyzed using t-test.